PreprintCC BY 4.0PsyArXiv
What this trial tells us about modified manualised psychodynamic psychotherapy for schizophrenia—and what it cannot
Abstract
Montag and colleagues report a randomised trial of modified psychodynamic psychotherapy for schizophrenia (MPP-S) plus treatment as usual (TAU) versus TAU alone. We welcome efforts to strengthen the evidence base for psychodynamic psychotherapy. Given the limited access to psychological treatment for people with psychosis and the, at best, moderate effects of existing pharmacological and psychological interventions this is a valuable effort to advance evidence-based treatment in psychosis. Several methodological decisions, however, complicate interpretation of its findings.
Related
- Psychotherapy remains a human endeavor: Human therapy is valued more than AI-integrated therapy
- From Evidence to Practice: A Systematic Review of Implementation of Psychedelic-Assisted Psychotherapy
- Psychotherapy and Teletherapy in U.S. Latinx Populations: A Narrative Review
- Sensory Regulation, Theraplay®, Eye Movement Desensitisation and Reprocessing, and Dyadic Developmental Psychotherapy Integration (STEDi) for Adoptive Children who have Experienced Developmental Trauma and Attachment Disruptions: A Mixed-Methods Preliminary Evaluation
- Simulating Psychotherapeutic Sessions with Generative Artificial Intelligence: A Proof-of-Concept Study of In Silico Psychotherapy Research
BibTeX
@misc{pillny2026what,
title = {{What this trial tells us about modified manualised psychodynamic psychotherapy for schizophrenia—and what it cannot}},
author = {Matthias Pillny and Stefan Leucht and Björn Schlier},
howpublished = {PsyArXiv},
year = {2026},
month = sep,
doi = {10.31234/osf.io/euhtq_v1},
url = {https://osf.io/preprints/psyarxiv/euhtq_v1/},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - What this trial tells us about modified manualised psychodynamic psychotherapy for schizophrenia—and what it cannot
AU - Matthias Pillny
AU - Stefan Leucht
AU - Björn Schlier
PY - 2026
DA - 2026/09/30
PB - PsyArXiv
DO - 10.31234/osf.io/euhtq_v1
UR - https://osf.io/preprints/psyarxiv/euhtq_v1/
AB - Montag and colleagues report a randomised trial of modified psychodynamic psychotherapy for schizophrenia (MPP-S) plus treatment as usual (TAU) versus TAU alone. We welcome efforts to strengthen the evidence base for psychodynamic psychotherapy. Given the limited access to psychological treatment for people with psychosis and the, at best, moderate effects of existing pharmacological and psychological interventions this is a valuable effort to advance evidence-based treatment in psychosis. Several methodological decisions, however, complicate interpretation of its findings.
ER -